Skip to main content
2026 CRT Conference Main banner

CRT 2026

Coronary

Session:: Coronary, Physiology and CMD | Sunday

CLINICAL OUTCOMES | CMD CLINICAL SCENARIO AND CONSIDERATION

Sunday, March 8, 2026
10:00 AM - 11:45 AM EST
Location: Lincoln

    Moderator(s)

  • Shrilla Banerjee, MD, FRCP, FESC

    Consultant Interventional Cardiologist
    Surrey and Sussex Healthcare NHS Trust
    Redhill, England, United Kingdom

    Disclosure(s): General Electric: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 10, 2025)

  • Nathaniel R. Smilowitz, MD

    Assistant Professor of Medicine
    NYU Langone Health
    New York, New York, United States

    Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); AngioInsight: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Pieter C. Smits, PhD, FESC

    Chief Medical Director
    CERC (Cardiovascular European Research Center)
    Rotterdam, Zuid-Holland, Netherlands

    Disclosure information not submitted.

Disclosure(s):
Shrilla Banerjee, MD, FRCP, FESC: General Electric: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 10, 2025)
Nathaniel R. Smilowitz, MD: Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); AngioInsight: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)